AP

Arti Paliwal

Active Director Director DIN 08635680
DIN 08635680 First appointment Dec 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Arti Paliwal

Data last updated:

Arti Paliwal is a Director at Vollmond Dermaceuticals Private Limited (since 2019). The company operates in Trading. Vollmond Dermaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2023).

DIN 08635680
Primary Designation Director
Industry Trading
First Appointment 11 Dec 2019
Oldest Company Age 6 yrs
Largest company Vollmond Dermaceuticals Private Limited · ₹6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Dec 20192019₹6 Lakh (FY 2023)Active

Board colleagues of Arti Paliwal

NameDINCompanyDesignation
Purnendu Paliwal08635681Vollmond Dermaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vollmond Dermaceuticals Private Limited
Premium access

Shareholding and investment profile for Arti Paliwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arti Paliwal

Arti Paliwal currently holds 1 directorship: Vollmond Dermaceuticals Private Limited (Director, since 11 Dec 2019, revenue ₹6 Lakh (FY 2023)).

Arti Paliwal was first appointed on 11 Dec 2019 as Director at Vollmond Dermaceuticals Private Limited.

The current boards of Arti Paliwal's companies include Purnendu Paliwal (Vollmond Dermaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available